The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center

• Y. Matsui,
• D. Ogata,
• Y. Nakayama,
• S. Wada,
• S. Tsuruta,
• E. Nakano,
• K. Namikawa,
• H. Uhara,
• N. Yamazaki

Affiliations

Y. Matsui

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan; Sapporo Medical University School of Medicine, Department of Dermatology, Sapporo, Japan

D. Ogata

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

Y. Nakayama

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

S. Wada

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

S. Tsuruta

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

E. Nakano

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

K. Namikawa

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan

H. Uhara

Sapporo Medical University School of Medicine, Department of Dermatology, Sapporo, Japan

N. Yamazaki

National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan